Organon successfully acquires Dermavant Sciences Ltd. to expand dermatology portfolio
Acquiring Company
Organon
Acquired Company
Dermavant
Jersey CityLong BeachBiotechnologyHealth CareMedicalBiotechnologyHealth CareTherapeuticsDescription
Organon, a global healthcare company, has successfully completed the acquisition of Dermavant Sciences Ltd. This acquisition allows Organon to expand its dermatology portfolio, integrating the innovative VTAMA® (tapinarof) cream, 1%, and reinforcing its commitment to addressing unmet healthcare needs, particularly in the field of immuno-dermatology.
Other recent acquisitions in Medical and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Flashpoint Therapeutics announces $50M Partnership with KAIMRC and Clinical Pipeline Expansion (November 14, 2024)
- Breeze Holdings Acquisition Corp. to merge with YD Biopharma Limited to revolutionize cancer prevention diagnostics (September 25, 2024)
- Flat Medical strengthens market leadership with acquisition of InjeQ assets, including FDA-Designated Breakthrough Device IQ-Tip® (September 25, 2024)
- Organon acquires Dermavant Sciences to obtain the groundbreaking skin treatment VTAMA® (tapinarof) cream 1% (September 19, 2024)
- Organon to Acquire Dermavant Sciences Ltd. with Focus on Innovative Dermatologic Therapy VTAMA® (tapinarof) Cream, 1% (September 18, 2024)
Who to call at Organon, and when
When Organon changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Organon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Organon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Organon. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Organon makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Dermavant?
Dermavant was acquired by Organon, based in Jersey City. The deal was reported on October 28, 2024. Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Organon is publicly traded (OGN) and operates in Biotechnology.
When did Organon acquire Dermavant?
Organon's acquisition of Dermavant was reported on October 28, 2024. Organon, a global healthcare company, has successfully completed the acquisition of Dermavant Sciences Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Dermavant do?
Dermavant is a biopharmaceutical company that specializes in developing innovative therapies for dermatological conditions. The company focuses on addressing unmet needs in dermatology. It aims to improve patients' lives with its innovative solutions. It is privately held, operating in Biotechnology, and is based in Long Beach.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.